Targeted Delivery Systems for Molecular Therapy in Skeletal Disorders

Area of Science:

• Bone biology and skeletal development.
• Pharmacology and drug delivery systems.
• Nanomedicine and biomaterials.

Background:

• Skeletal disorders involve abnormalities in bone matrix, mineral, and cells, impacting development and homeostasis.
• Current systemic drug administration for skeletal disorders has low efficacy and high toxicity risks.
• Targeted drug delivery is crucial for enhancing therapeutic outcomes in skeletal tissues.

Purpose of the Study:

• To review recent advancements in targeted drug delivery for skeletal disorders.
• To explore the use of targeting moieties and nanoparticles in bone-targeted therapies.
• To discuss the clinical translation potential of these advanced drug delivery systems.

Main Methods:

• Review of literature on targeting moieties for skeletal applications.
• Analysis of nanoparticle-based drug delivery systems for bone disorders.
• Discussion of clinical challenges and future perspectives in targeted bone therapy.

Main Results:

• Various targeting moieties and nanoparticles show promise for bone-specific drug delivery.
• Targeted systems can improve drug concentration in skeletal tissues.
• Reduced systemic toxicity is a key advantage of targeted approaches.

Conclusions:

• Targeted drug delivery systems represent a significant advancement in treating skeletal disorders.
• Further research and clinical trials are needed to optimize nanoparticle and moiety selection for translation.
• Nanoparticle-based targeted therapies hold great potential for improving skeletal health and patient outcomes.